Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines

Experimental Cell Research

Volumn 305, Issue 1, 2005, Pages 83-98

  Bachmeier, Beatrice E ^a   Albini, Adriana ^b   Vené, Roberta ^b   Benelli, Roberto ^b   Noonan, Douglas ^b   Weigert, Cora ^c   Weiler, Christoph ^a   Lichtinghagen, Ralf ^d   Jochum, Marianne ^a   Nerlich, Andreas G ^e  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

AP 1; Breast cancer; Cell density; In vitro study; Invasion; MMP regulation; mRNA; Tumor cell lines

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PROTEIN C FOS; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENICITY; CELL DENSITY; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION;

EID: 20144378487     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.12.019     Document Type: Article

References (48)

1. A. Albini, and A. Colacci Inhibition of malignant tumor cell invasion: an approach to anti-progression Basic Life Sci. 61 1993 335 350
2. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev., Cancer 2 2002 161 174
3. P. Henriet, L. Blavier, and Y.A. Declerck Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation APMIS 107 1999 111 119
4. T. Yoshizaki, Y. Maruyama, H. Sato, and M. Furukawa Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma Int. J. Cancer 95 2001 44 50
5. M.P. Vincenti The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression Methods Mol. Biol. 151 2001 121 148
6. J. Westermarck, and V.M. Kahari Regulation of matrix metalloproteinase expression in tumor invasion FASEB J. 13 1999 781 792
7. M.R. Bergman, S. Cheng, N. Honbo, L. Piacentini, J.S. Karliner, and D.H. Lovett A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers Biochem. J. 369 2003 485 496
8. Y. Chinenov, and T.K. Kerppola Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity Oncogene 20 2001 2438 2452
9. S. Menashi, M. Dehem, I. Souliac, Y. Legrand, and R. Fridman Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells Int. J. Cancer 75 1998 259 265
10. T. Igarashi, M. Abe, M. Oikawa, T. Nukiwa, and Y. Sato Retinoic acids repress the expression of ETS-1 in endothelial cells J. Tohoku Exp. Med. 194 2001 35 43
11. B.E. Bachmeier, A.G. Nerlich, R. Lichtinghagen, and C.P. Sommerhoff Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity Anticancer Res. 21 2001 3821 3828
12. B.E. Bachmeier, A.G. Nerlich, P. Boukamp, R. Lichtinghagen, H. Tschesche, H. Fritz, and E. Fink Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1 Biol. Chem. 381 2000 509 516
13. B.E. Bachmeier, P. Boukamp, R. Lichtinghagen, N.E. Fusenig, and E. Fink Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines Biol. Chem. 381 2000 497 507
14. U. Benbow, M.P. Schoenermark, K.A. Orndorff, A.L. Givan, and C.E. Brinckerhoff Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid Clin. Exp. Metastasis 17 1999 231 238
15. M. Balduyck, F. Zerimech, V. Gouyer, R. Lemaire, B. Hemon, G. Grard, C. Thiebaut, V. Lemaire, E. Dacquembronne, T. Duhem, A. Lebrun, M.J. Dejonghe, and G. Huet Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro Clin. Exp. Metastasis 18 2000 171 178
16. L.C. Meade-Tollin, P. Boukamp, N.E. Fusenig, C.P. Bowen, T.C. Tsang, and G.T. Bowden Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes Br. J. Cancer 77 1998 724 730
17. A. Lebeau, C. Muller-Aufdemkamp, C. Allmacher, U. Sauer, A. Nerlich, R. Lichtinghagen, and U. Lohrs Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth J. Mol. Histol. 35 2004 443 455
18. B.E. Bachmeier, H. Rohrbach, J. DeWaal, and A. Nerlich Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas Int. J. Oncol. 26 2004 1 13
19. J.E. Price, A. Polyzos, R.D. Zhang, and L.M. Daniels Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice Cancer Res. 50 1990 717 721
20. R.D. Zhang, I.J. Fidler, and J.E. Price Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis Invasion Metastasis 11 1991 204 215
21. H.D. Soule, J. Vazguez, A. Long, S. Albert, and M. Brennan A human cell line from a pleural effusion derived from a breast carcinoma J. Natl. Cancer Inst. 51 1973 1409 1416
22. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
23. A. Albini Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms Pathol. Oncol. Res. 4 1998 230 241
24. A. Albini, Y. Iwamoto, H.K. Kleinman, G.R. Martin, S.A. Aaronson, J.M. Kozlowski, and R.N. McEwan A rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Res. 47 1987 3239 3245
25. H.K. Kleinman, M.L. McGarvey, J.R. Hassell, V.L. Star, F.B. Cannon, G.W. Laurie, and G.R. Martin Basement membrane complexes with biological activity Biochemistry 25 1986 312 318
26. R. Lichtinghagen, T. Helmbrecht, B. Arndt, and K.H. Boker Expression pattern of matrix metalloproteinases in human liver Eur. J. Clin. Chem. Clin. Biochem. 33 1995 65 71
27. R. Netzker, C. Weigert, and K. Brand Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene Eur. J. Biochem. 245 1997 174 181
28. P. Angel, K. Hattori, T. Smeal, and M. Karin The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 Cell 55 1988 875 885
29. M. Morini, M. Mottolese, N. Ferrari, F. Ghiorzo, S. Buglioni, R. Mortarini, D.M. Noonan, P.G. Natali, and A. Albini The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity Int. J. Cancer 87 2000 336 342
30. U. Benbow, and C.E. Brinckerhoff The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15 1997 519 526
31. A.E. Kossakowska, S.A. Huchcroft, S.J. Urbanski, and D.R. Edwards Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans Br. J. Cancer 73 1996 1401 1408
32. K. Airola, T. Karonen, M. Vaalamo, K. Lehti, J. Lohi, A.L. Kariniemi, J. Keski-Oja, and U.K. Saarialho-Kere Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas Br. J. Cancer 80 1999 733 743
33. G.I. Murray, M.E. Duncan, P. O'Neil, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer Nat. Med. 2 1996 461 462
34. B. Tetu, J. Brisson, H. Lapointe, and P. Bernard Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer Hum. Pathol. 29 1998 979 985
35. L. Nakopoulou, I. Giannopoulou, H. Gakiopoulou, H. Liapis, A. Tzonou, and P.S. Davaris Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features Hum. Pathol. 30 1999 436 442
36. E.A. Garbett, M.W. Reed, and N.J. Brown Proteolysis in human breast and colorectal cancer Br. J. Cancer 81 1999 287 293
37. U. Benbow, J.L. Rutter, C.H. Lowrey, and C.E. Brinckerhoff Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter Br. J. Cancer 79 1999 221 228
38. H.S. Azzam, G. Arand, M.E. Lippman, and E.W. Thompson Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production J. Natl. Cancer Inst. 85 1993 1758 1764
39. L.M. Smith, S.C. Wise, D.T. Hendricks, A.L. Sabichi, T. Bos, P. Reddy, P.H. Brown, and M.J. Birrer cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype Oncogene 18 1999 6063 6070
40. M. Kirstein, L. Sanz, S. Quinones, J. Moscat, M.T. Diaz-Meco, and J. Saus Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene J. Biol. Chem. 271 1996 18231 18236
41. J.L. Rutter, U. Benbow, C.I. Coon, and C.E. Brinckerhoff Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells J. Cell. Biochem. 66 1997 322 336
42. B. Xie, C.D. Bucana, and I.J. Fidler Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells Am. J. Pathol. 144 1994 1058 1067
43. P. Behrens, M. Rothe, A. Wellmann, J. Krischler, and N. Wernert The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer J. Pathol. 194 2001 43 50
44. H. Yabe, M. Fukuma, F. Urano, K. Yoshida, S. Kato, Y. Toyama, J. Hata, and A. Umezawa Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo Biochem. Biophys. Res. Commun. 293 2002 61 71
45. A. Lebeau, A.G. Nerlich, U. Sauer, R. Lichtinghagen, and U. Lohrs Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas Anticancer Res. 19 1999 4257 4264
46. E.A. Garbett, M.W. Reed, T.J. Stephenson, and N.J. Brown Proteolysis in human breast cancer Mol. Pathol. 53 2000 99 106
47. C. Clavel, M. Polette, M. Doco, I. Binninger, and P. Birembaut Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology Bull. Cancer 79 1992 261 270
48. H. Hagedorn, M. Schreiner, I. Wiest, J. Tubel, E.D. Schleicher, and A.G. Nerlich Defective basement membrane in laryngeal carcinomas with heterogeneous loss of distinct components Hum. Pathol. 29 1998 447 454